Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for testicular cancer genes in families

NCT ID NCT00034424

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 12 times

Summary

This study aims to understand why testicular cancer sometimes runs in families. Researchers will collect DNA samples and medical information from about 750 people in families with multiple cases of testicular cancer. No treatment is given; the goal is to find genes that increase risk and learn more about the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

749 people

The number who actually took part.

Started

Jan 2003

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

A non-randomized cohort study of individuals from families with a significant history of testicular cancer.

Ages

12 to 77 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: Study population: Patients must be members of families with familial TGCT as defined below. Definition of familial TGCT: The criterion establishing familial TGCT is the presence of: -at least two cases of documented GCT in blood relatives (at least one of which is testicular in origin), OR * a single family member with bilateral testicular cancer, * men with a history of TGCT who are one in a set of identical siblings will also be included in the study. Case definition: A case will be determined to have TGCT according to the following criteria: * Pathologic confirmation of a germ cell derived tumor arising in the testis. Extragonadal germ cell tumors will also be included. * Germ cell derived histologies including: seminoma, germinoma, embryonal carcinoma, endodermal sinus (yolk sac) tumor, gonadoblastoma, choriocarcinoma, teratoma, and mixed germ cell tumor. * A case will be determined to have TIN on the basis of pathologic confirmation of intratubular malignant germ cells (ITMGCs) as defined by Burke and Mostofi. Individuals from participating families who are eligible for this study include: i) all TGCT cases; ii) all GCT cases (including those of ovarian or extra-gonadal sites); iii) all first-degree relatives of each GCT case; iv) the spouse(s) of every case if the spouse and case had children who are participating in the study; v) any blood relative not included in (ii - iii) above who genetically links two cases; and vi) any blood relative with cancer other than GCT vii) family members as described in i) - v) above must be age 12 or greater in order to participate EXCLUSION CRITERIA: Families will be deemed ineligible for participation in this study if: There are not at least two confirmed cases of GCT in the family, (at least one of which is testicular in origin), unless there is a family member with bilateral testicular cancer; Deceased TGCT cases lacking both archival sources of tissue for DNA extraction AND lacking surviving spouses and children who are willing to participate in the study (the unavailability of such persons prohibits inferring the genotype of the deceased individual with TGCT); Critical informative family members are unwilling to participate (i.e., unwilling to provide written informed consent);

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extragonadal germ cell tumor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.